Journal of Autacoids Open Access

  • Journal h-index: 4
  • Journal CiteScore: 1.06
  • Journal Impact Factor: 1.37
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

Abstract

Reviews: Serum Anticholinergic Activity: A Biomarker for Rapid Progression of Alzheimer's Disease

Koji Hori

We have antecedently according the probabilities that anticholinergic activity (AA) appeared endogenously in Alzheimer’s malady (AD) and accelerated AD pathology. during this article we tend to reviewed the explanations why AA endogenously appeared in AD and accelerated AD pathology which the humor anticholinergic activity (SAA) was appropriate collectively of the biological marker of AD. we tend to argued first of all that associate acethycholine (Ach) vie a task to take care of associate endogenous medicament pathway within the brain and also the peripheral tissue. Secondarily, the deficiency of Ach within the brain may trigger the inflammatory method in AD patients by means of the suppression of cholinergic medicament pathway and AA may be generated by inflammatory method. At third, AA disturbed not solely memory functions however additionally accelerated AD pathology (increasing of amyloidgenic), and at fourth, we tend to projected an opening that the SAA was helpful as a marker of speedy progression of AD pathology within the moderate stage. SAA was thought-about to look at moderate stage of AD once the symptoms quickly were progress associated an inflammation was occurred within the brain. The activities of N-methyl-D-aspartate (NMDA) receptors were accelerated associated it progressed an inflammation within the brain. Memantine ought to be prescribed to AD patients with positive SAA so as to suppress inflammation by antagonizing the NMDA receptor. Therefore, once SAA was detected in AD, it ought to be thought-about to impose memantine.